The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/183480
2013 CMO Leadership Awards Winner Profiles Therapure Biopharma Inc. Mississauga, Ontario, Canada Manufacturing locations: Mississauga, Ontario, Canada www.therapurebio.com (905) 286-6270 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Contact: Dina Iezzi diezzi@therapurebio.com DRUG LIFE CYCLE STAGES: Research & Development — discovery, preclinical, and clinical (phase 1, phase 2, and phase 3); Drug Substance Production — primary process development and drug substance production; Formulated Drug Production — dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, injectables, lyophilized products, ophthalmics, parenterals (small volume), proteins, sterile, syringes (prefilled), and vaccines. "It is an honor to be recognized for a third consecutive year for the CMO Leadership Award, and once again in all five categories (quality, reliability, innovation, productivity, and regulatory). This award reinforces the diligence, passion, and contribution of our employees, who strive to produce the highest quality therapeutics possible. The five categories are critical to our clients', as well as our organization's success, but more importantly, critical for patient wellbeing." – Nick Green, president and CEO UPM Pharmaceuticals, Inc. Baltimore, MD Manufacturing locations: Baltimore, MD www.upm-inc.com (410) 843-3700 DRUG TYPE: Pharmaceuticals Contact: Mike Raum raum@upm-inc.com DRUG LIFE CYCLE STAGES: Research & Development — preclinical, clinical (phase 1, phase 2, and phase 3); Formulated Drug Production — dosage form development, dosage form production, packaging (phase 1 through commercial) SERVICES OFFERED: Capsules, tablets, controlled substances, cytotoxic & high-potency compounds, gels, generics, liquids, nonsterile peptides, powders (nonsterile), semisolids, solutions & suspensions, and topicals. "UPM Pharmaceuticals focuses on meeting challenging timelines for development work, provision of clinical supplies, and associated lab services. UPM maintains a lean and flat corporate structure. This allows production decisions and quality oversight on every project to be made and driven daily with input from every department and overseen at the highest levels of our operations. We pride ourselves on providing constant communication with our clients. UPM clearly understands winning and keeping business in this highly competitive industry is about producing results for our clients." — Jim Gregory, president and COO DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Vetter Ravensburg, Germany Manufacturing locations: Langenargen, Germany; Ravensburg, Germany; Skokie, IL, U.S.A. www.vetter-pharma.com +49-751-3700-0 Contact: Oskar Gold info@vetter-pharma.com DRUG LIFE CYCLE STAGES: Research & Development — preclinical, clinical (phase 1, phase 2, and/or phase 3); Formulated Drug Production — dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, cartridges, injectables, liquids, lyophilized products, parenterals (large volume), parenterals (small volume), peptides, proteins, solutions & suspensions, sterile, syringes (prefilled), and vaccines. "We at Vetter work diligently to meet regulatory requirements. As a full CDMO that specializes in the aseptic filling of syringes, cartridges, and vials, maintaining high-quality standards is a job we take seriously to be a reliable and efficient partner for our customers." — Joachim del Boca, vice president regulatory affairs/quality compliance 46 The CMO Leadership Awards 2013